These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 19681008)
1. Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III. Tchan MC; Sillence D J Intellect Dev Disabil; 2009 Sep; 34(3):275-9. PubMed ID: 19681008 [TBL] [Abstract][Full Text] [Related]
3. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Lapointe JS; Honer WG Am J Psychiatry; 2004 Oct; 161(10):1829-36. PubMed ID: 15465980 [TBL] [Abstract][Full Text] [Related]
4. Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland. Greil W; Häberle A; Schuhmann T; Grohmann R; Baumann P Swiss Med Wkly; 2013; 143():w13772. PubMed ID: 23821346 [TBL] [Abstract][Full Text] [Related]
5. A comparison of two novel antipsychotics in first episode non-affective psychosis: one-year outcome on symptoms, motor side effects and cognition. Malla A; Norman R; Scholten D; Townsend L; Manchanda R; Takhar J; Haricharan R Psychiatry Res; 2004 Dec; 129(2):159-69. PubMed ID: 15590043 [TBL] [Abstract][Full Text] [Related]
6. Extrapyramidal symptoms resulting from risperidone use in a four year old child: A case report. Elahi E; Zia U; Bhutta OA; Andleeb S J Pak Med Assoc; 2018 Nov; 68(11):1719-1720. PubMed ID: 30410159 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD). Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416 [TBL] [Abstract][Full Text] [Related]
8. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Conley RR; Mahmoud R Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400 [TBL] [Abstract][Full Text] [Related]
9. Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model. Vera-Llonch M; Delea TE; Richardson E; Rupnow M; Grogg A; Oster G Value Health; 2004; 7(5):569-84. PubMed ID: 15367252 [TBL] [Abstract][Full Text] [Related]
10. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775 [TBL] [Abstract][Full Text] [Related]
11. A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour. Shah A; Suh GH Int Psychogeriatr; 2005 Mar; 17(1):12-22; discussion 22-9. PubMed ID: 15945589 [No Abstract] [Full Text] [Related]
12. Risperidone for the treatment of behavioral and psychological symptoms of dementia. Tune LE J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986 [TBL] [Abstract][Full Text] [Related]
14. Self-reported side effects in children and adolescents taking risperidone. Byrne S; Walter G; Hunt G; Soh N; Cleary M; Duffy P; Crawford G; Krabman P; Concannon P; Malhi G Australas Psychiatry; 2010 Feb; 18(1):42-5. PubMed ID: 20136533 [TBL] [Abstract][Full Text] [Related]
15. Meige's syndrome associated with risperidone therapy. Ananth J; Burgoyne K; Aquino S Am J Psychiatry; 2000 Jan; 157(1):149. PubMed ID: 10618045 [No Abstract] [Full Text] [Related]
16. [Psychopharmacological treatment of behavioral and psychological symptoms in dementia]. Lolk A; Gulmann NC Ugeskr Laeger; 2006 Oct; 168(40):3429-32. PubMed ID: 17032610 [TBL] [Abstract][Full Text] [Related]
17. Switching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone: evaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight loss. Andersen TH; Bech P; Larsen NE Nord J Psychiatry; 2005; 59(3):205-8. PubMed ID: 16195121 [TBL] [Abstract][Full Text] [Related]
18. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone. Aman MG; Gharabawi GM; J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046 [TBL] [Abstract][Full Text] [Related]
19. Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study. Hori H; Ueda N; Yoshimura R; Yamamoto H; Wani K; Etoh Y; Haraga K; Kitahara J; Nakamura J World J Biol Psychiatry; 2009; 10(4 Pt 3):741-5. PubMed ID: 19707954 [TBL] [Abstract][Full Text] [Related]
20. New for old? Risperidone long-acting injection in older patients. Hudson-Jessop P; Hughes B; Brinkley N Australas Psychiatry; 2007 Dec; 15(6):461-4. PubMed ID: 17999255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]